5Watanabe T,Nakamura M,Kros JM,et al.Phenotype versus genetype correlation in oligodendrogliomas and low-grade diffuse astrocytomas[J].Acta Neuropathol,2002,103:267-275.
6Rosenblum MK.Ependymal tumor:A review of their diagnostic surgical pathology[J].Pediatr Neurosurg,1998,28:160-165.
7Watanabe T,Nakamura M,Yoshino A,et al.Deregulation of the TP53/P14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course[J].Clin Cancer Res,2003,101:185 -189.
8Perry A,Ander LK,Borell TJ,et al.Detection of P16,RB,CDK4 and P53 gene deletion and amplification by fluorescence in situ hybridization in 96 gliomas[J].Am J Clin Pathol,1999,112:801 -809.
3van der Velden M, Bots GT, Endtz LJ. Cranial CT in multiple sclerosis showing a mass effect. Surg Neurol,1979, 12:307-310.
4Rieth KG, Di Chiro G, Cromwell LD, et al. Primary demyelinating disease simulating gliomas of the corpus callosum: report of three cases. J Neurosurg,1981,55:620-624.
5Kalyan-Raman UP, Garwacki DJ, Elwood PW. Demyelinating disease of corpus callosum presenting as glioma on magnetic resonance scan: a case documented with pathological findings. Neurosurgery, 1987, 21:247-250.
6Kepes JJ. Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis?A study of 31 patients. Ann Neurol,1993, 33: 18-27.
7Weinshenker BG, O′Brien PC, Petterson JM,et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol, 1999,46: 878-886.
8Rosenblum MK, Bilbao JM, Ang LC. Neuromuscular system. In: Rosai J. Ackerman′s surgical pathology. 8th ed.St Louis: Mosby,1996.2245-2247.
9Watanabe K,Tachibana O, Sata K, et al. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol, 1996,6,217-224.
